Current Medicinal Chemistry - Central Nervous System Agents
Title: Preface
Volume: 3 Issue: 1
Author(s): Gregory S. Hamilton
Affiliation:
Export Options
About this article
Cite this article as:
Hamilton S. Gregory, Preface, Current Medicinal Chemistry - Central Nervous System Agents 2003; 3 (1) . https://dx.doi.org/10.2174/1568015033357814
DOI https://dx.doi.org/10.2174/1568015033357814 |
Print ISSN 1568-0150 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6158 |
Article Metrics
Related Articles
-
Recent Progress in the Preparation of Eco-friendly Lubricant and Fuel Additives through Organic Transformations of Biomaterials
Mini-Reviews in Organic Chemistry Myxedema Heart Disease: A Rare Disease Entity: Case Report and Brief Review of the Literature
Current Hypertension Reviews Do RAS Inhibitors Protect the Brain from Cerebral Ischemic Injury?
Current Hypertension Reviews The Role of Inflammatory Biomarkers in the Detection and Therapy of Atherosclerotic Disease
Current Vascular Pharmacology Hybrid Therapy in the Management of Atrial Fibrillation
Current Cardiology Reviews Anti-Platelet Therapy for Acute Coronary Syndrome: A Review of Currently Available Agents and What the Future Holds
Cardiovascular & Hematological Disorders-Drug Targets Immunobiologic Agents in Dermatology
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Use of Sulfated Fucans as Anticoagulant and Antithrombotic Agents: Future Perspectives
Current Pharmaceutical Design Nicotinamide Phosphoribosyltransferase (NAMPT) Inhibitors as Therapeutics: Rationales, Controversies, Clinical Experience
Current Drug Targets Fast Food Versus Slow Food and Hypertension Control
Current Hypertension Reviews “Connecting the Dots” from Blood Brain Barrier Dysfunction to Neuroinflammation and Alzheimer’s Disease
Current Neurovascular Research Platelets in Cardiovascular Imaging
Current Vascular Pharmacology Histone Deacetylase (HDAC) Inhibitors as Potential Drugs to Target Memory and Adult Hippocampal Neurogenesis
Current Psychopharmacology Neuropharmacology of Organoselenium Compounds in Mental Disorders and Degenerative Diseases
Current Medicinal Chemistry The Role of IRE1 Signaling in the Central Nervous System Diseases
Current Neuropharmacology Involvement of Immune Response in the Pathogenesis of Amyotrophic Lateral Sclerosis: A Therapeutic Opportunity?
CNS & Neurological Disorders - Drug Targets Diabetic Papillopathy: Current and New Treatment Options
Current Diabetes Reviews Comparing Perfusion Data of CE-MRI, SWI, and CTA with MR Perfusion in Stroke
Current Medical Imaging Nanoparticulated Nitric Oxide Donors and their Biomedical Applications
Mini-Reviews in Medicinal Chemistry Nose-to-Brain Drug Delivery by Nanoparticles in the Treatment of Neurological Disorders
Current Medicinal Chemistry